IMMUNE NETWORK

  • 제25권2호
  • /
  • Pages.2.1-2.15
  • /
  • 2025
  • /
  • 1598-2629(pISSN)
  • /
  • 2092-6685(eISSN)
대한면역학회 (The Korean Association of Immunobiologists)
권호 표지
DOI QR코드

DOI QR Code

Synovial Fluid as a Crucial Component of the Joint Microenvironment in Rheumatoid Arthritis

  • 투고 : 2024.05.23
  • 심사 : 2024.12.22
  • 발행 : 2025.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Rheumatoid arthritis (RA) is a systemic autoimmune disease closely associated with synovial tissue proliferation, pannus formation in small joints such as the hands, wrists, and feet, cartilage destruction, and systemic complications such as pulmonary, cardiovascular, neurological, and skeletal muscle lesions, glucocorticoid-induced osteoporosis and infections. The importance of confirming the diagnosis and determining local activity is given to the study of synovial fluid. A deep understanding of the pathological process in the joint in RA, characterized by changes in autoreactive CD4+ T cells, B cells, macrophages, inflammatory cytokines, chemokines, and autoantibodies, has now been achieved, although much remains to be explored. This article provides an updated overview of the pathogenesis of RA, revealing even more therapeutic targets for the intra-articular pathological process.

키워드

참고문헌

  1. Takeuchi Y, Hirota K, Sakaguchi S. Synovial tissue inflammation mediated by autoimmune T cells. Front Immunol 2019;10:1989. https://doi.org/10.3389/fimmu.2019.01989
  2. Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA 2018;320:1360-1372. https://doi.org/10.1001/jama.2018.13103
  3. Bullock J, Rizvi SAA, Saleh AM, Ahmed SS, Do DP, Ansari RA, Ahmed J. Rheumatoid arthritis: a brief overview of the treatment. Med Princ Pract 2018;27:501-507. https://doi.org/10.1159/000493390
  4. Radu AF, Bungau SG. Management of rheumatoid arthritis: an overview. Cells 2021;10:2857. https://doi.org/10.3390/cells10112857
  5. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet 2016;388:2023-2038. https://doi.org/10.1016/S0140-6736(16)30173-8
  6. Yamada H. The search for the pathogenic T cells in the joint of rheumatoid arthritis: which T-cell subset drives autoimmune inflammation? Int J Mol Sci 2023;24:6930. https://doi.org/10.3390/ijms24086930
  7. Finckh A, Gilbert B, Hodkinson B, Bae SC, Thomas R, Deane KD, Alpizar-Rodriguez D, Lauper K. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol 2022;18:591-602. https://doi.org/10.1038/s41584-022-00827-y
  8. Kłak A, Raciborski F, Samel-Kowalik P. Social implications of rheumatic diseases. Reumatologia 2016;54:73-78. https://doi.org/10.5114/reum.2016.60216
  9. Grassi W, De Angelis R, Lamanna G, Cervini C. The clinical features of rheumatoid arthritis. Eur J Radiol 1998;27 Suppl 1:S18-S24. https://doi.org/10.1016/S0720-048X(98)00038-2
  10. Conforti A, Di Cola I, Pavlych V, Ruscitti P, Berardicurti O, Ursini F, Giacomelli R, Cipriani P. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev 2021;20:102735. https://doi.org/10.1016/j.autrev.2020.102735
  11. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-668. https://doi.org/10.1038/283666a0
  12. Matsumoto I, Maccioni M, Lee DM, Maurice M, Simmons B, Brenner M, Mathis D, Benoist C. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol 2002;3:360-365. https://doi.org/10.1038/ni772
  13. Matsumoto I, Staub A, Benoist C, Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 1999;286:1732-1735. https://doi.org/10.1126/science.286.5445.1732
  14. Sakaguchi S, Takahashi T, Hata H, Nomura T, Sakaguchi N. SKG mice, a new genetic model of rheumatoid arthritis. Arthritis Res 2003;5 Suppl 3:10. https://doi.org/10.1186/ar811
  15. Guerard S, Boieri M, Hultqvist M, Holmdahl R, Wing K. The SKG mutation in ZAP-70 also confers arthritis susceptibility in C57 black mouse strains. Scand J Immunol 2016;84:3-11. https://doi.org/10.1111/sji.12438
  16. Leipe J, Grunke M, Dechant C, Reindl C, Kerzendorf U, Schulze-Koops H, Skapenko A. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum 2010;62:2876-2885. https://doi.org/10.1002/art.27622
  17. Yang P, Qian FY, Zhang MF, Xu AL, Wang X, Jiang BP, Zhou LL. Th17 cell pathogenicity and plasticity in rheumatoid arthritis. J Leukoc Biol 2019;106:1233-1240. https://doi.org/10.1002/JLB.4RU0619-197R
  18. Sayegh S, El Atat O, Diallo K, Rauwel B, Degboé Y, Cavaignac E, Constantin A, Cantagrel A, Trak Smayra V, Alaaeddine N, et al. Rheumatoid synovial fluids regulate the immunomodulatory potential of adipose-derived mesenchymal stem cells through a TNF/NF-κB-dependent mechanism. Front Immunol 2019;10:1482. https://doi.org/10.3389/fimmu.2019.01482
  19. Rai P, Janardhan KS, Meacham J, Madenspacher JH, Lin WC, Karmaus PWF, Martinez J, Li QZ, Yan M, Zeng J, et al. IRGM1 links mitochondrial quality control to autoimmunity. Nat Immunol 2021;22:312-321. https://doi.org/10.1038/s41590-020-00859-0
  20. Ma C, Wang J, Hong F, Yang S. Mitochondrial dysfunction in rheumatoid arthritis. Biomolecules 2022;12:1216. https://doi.org/10.3390/biom12091216
  21. Cui L, Weiyao), Chenghong S, Limei L, Xinghua Z, Bo Y, Xiaozheng D, Haidong W. Rheumatoid arthritis and mitochondrial homeostasis: the crossroads of metabolism and immunity. Front Med (Lausanne) 2022;9:1017650. https://doi.org/10.3389/fmed.2022.1017650
  22. Pawlik A, Ostanek L, Brzosko I, Brzosko M, Masiuk M, Machalinski B, Gawronska-Szklarz B. The expansion of CD4+CD28-T cells in patients with rheumatoid arthritis. Arthritis Res Ther 2003;5R210-R213. https://doi.org/10.1186/ar766
  23. Mellado M, Martinez-Munoz L, Cascio G, Lucas P, Pablos JL, Rodriguez-Frade JM. T cell migration in rheumatoid arthritis. Front Immunol 2015;6:384. https://doi.org/10.3389/fimmu.2015.00384
  24. Klareskog L, Lundberg K, Malmstrom V. Autoimmunity in rheumatoid arthritis: citrulline immunity and beyond. Adu Immunol 2013;118:129-158. https://doi.org/10.1016/B978-0-12-407708-9.00003-0
  25. Kotake S, Nanke Y, Yago T, Kawamoto M, Kobashigawa T, Yamanaka H. Ratio of circulating IFNγ (+) "Th17 cells" in memory Th cells is inversely correlated with the titer of anti-CCP antibodies in early-onset rheumatoid arthritis patients based on flow cytometry methods of the human immunology project. Biomed Res Int 2016;2016:9694289. https://doi.org/10.1155/2016/9694289
  26. Raza K, Falciani F, Curnow SJ, Ross EJ, Lee CY, Akbar AN, Lord JM, Gordon C, Buckley CD, Salmon M. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005;7R784-R795. https://doi.org/10.1186/ar1733
  27. Zhong W, Zhao L, Liu T, Jiang Z. IL-22-producing CD4+ T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide. Sci Rep 2017;7:41143. https://doi.org/10.1038/srep41143
  28. Zizzo G, De Santis M, Bosello SL, Fedele AL, Peluso G, Gremese E, Tolusso B, Ferraccioli G. Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. Clin Immunol 2011;138:107-116. https://doi.org/10.1016/j.clim.2010.10.002
  29. Rasmussen TK, Andersen T, Hvid M, Hetland ML, Horslev Petersen K, Stengaard Pedersen K, Holm CK, Deleuran B. Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. ] Rheumato 12010;37:2014-2020. https://doi.org/10.3899/jrheum.100259
  30. Krebs CF, Turner JE, Paust HJ, Kapffer S, Koyro T, Krohn S, Ufer F, Friese MA, Flavell RA, Stockinger B, et al. Plasticity of Th17 cells in autoimmune kidney diseases.] Immunol 2016:197:449-457. https://doi.org/10.4049/jimmunol.1501831
  31. van Hamburg JP, Tas SW. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis. J Autoimnnun 2018:87:69-81. https://doi.org/10.1016/j.jaut.2017.12.006
  32. Hirota K, Hashimoto M, Ito Y, Matsuura M, Ito H, Tanaka M, Watanabe H, Kondoh G, Tanaka A, Yasuda K, et al. Autoimmune Th17 cells induced synovial stromal and innate lymphoid cell secretion of the cytokine GM-CSF to initiate and augment autoimmune arthritis. Immunity 2018;48:1220-1232.e5. https://doi.org/10.1016/j.immuni.2018.04.009
  33. Avci AB, Feist E, Burmester GR. Targeting GM-CSF in rheumatoid arthritis. Clin Exp Rheumatol 2C16:34:39-44.
  34. Lee KMC, Achuthan AA, Hamilton JAGM. GM-CSF: a promising target in inflammation and autoimmunity. Immunotargets Ther 2020;9:225-240. https://doi.org/10.2147/ITT.S262566
  35. Önnheim K, Huang S, Strid Holmertz A, Andersson S, Lönnblom E, Jonsson C, Holmdahl R, Gjertsson I. Rheumatoid arthritis chondrocytes produce increased levels of pro-inflammatory proteins. Osteoarthr Cartil Open 2022;4:100235. https://doi.org/10.1016/j.ocarto.2022.100235
  36. Morshed A, Abbas AB, Hu J, Xu H. Shedding new light on the role of av33 and a531 integrins in rheumatoid arthritis. Molecules 2019;24:1537. https://doi.org/10.3390/molecules24081537
  37. Rani L, Kumar A, Karhade J, Pandey G, Guha A, Mishra GC, Wani MR. IL-3 regulates the differentiation of pathogenic Th17 cells. Eur J Immunol 2022;52:1842-1858. https://doi.org/10.1002/eji.202149674
  38. Ke Q Greenawalt AN, Manukonda V, Jix, Tisch RM. The regulation of self-tolerance and the role of inflammasome molecules. Front Immunol 2023:14:1154552. https://doi.org/10.3389/fimmu.2023.1154552
  39. Zhang Y, Yang W, Li W, Zhao Y. NLRP3 inflammasome: checkpoint connecting innate and adaptive immunity in autoimmune diseases. Front Immunol 2021;12:732933. https://doi.org/10.3389/fimmu.2021.732933
  40. Kim J, Gupta R, Blanco LP, Yang S, Shteinfer-Kuzmine A, Wang K, Zhu J, Yoon HE, Wang X, Kerkhofs M, et al. VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science 2019;366:1531-1536. https://doi.org/10.1126/science.aav4011
  41. Hajizadeh S, De Groot], Te Koppele JM, Tarkowski A, Collins LV. Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res Ther 2003;5:R234-R240. https://doi.org/10.1186/ar787
  42. Panga V, Kallor AA, Nair A, Harshan S, Raghunathan S. Mitochondrial dysfunction in rheumatoid arthritis: a comprehensive analysis by integrating gene expression, protein-protein interactions and gene ontology data. PLoS One 2019;14:e0224632. https://doi.org/10.1371/journal.pone.0224632
  43. Jaiswal KS, Khanna S, Ghosh A, Padhan P, Raghav SK, Gupta B. Differential mitochondrial genome in patients with rheumatoid arthritis. Autoimmunitu 2021;54:1-12. https://doi.org/10.1080/08916934.2020.1846182
  44. Tu J, Wang X, Gong X, Hong W, Han D, Fang Y, Guo Y, Wei W. Synovial macrophages in rheumatoid arthritis: the past, present, and future. Mediators Inflamm 2020;2020:1583647. https://doi.org/10.1155/2020/1583647
  45. Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996:39:115-124. https://doi.org/10.1002/art.1780390116
  46. Sakai M, Troutman TD, Seidman JS, Ouyang Z, Spann NJ, Abe Y, Ego KM, Bruni CM, Deng Z, Schlachetzki JCM, et al. Liver-derived signals sequentially reprogram myeloid enhancers to initiate and maintain Kupffer cell identity. Immunity 2019:51:655-670.e8. https://doi.org/10.1016/j.immuni.2019.09.002
  47. Liu Z, Gu Y, Chakarov S, Bleriot C, Kwok I, Chen X, Shin A, Huang W, Dress RJ, Dutertre CA, et al. Fate mapping via Ms4a3-expression history traces monocyte-derived cells. Cell 2019:178:1509-1525.e19. https://doi.org/10.1016/j.cell.2019.08.009
  48. Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res 2000;2:189-202. https://doi.org/10.1186/ar86
  49. Kurowska-Stolarska M, Alivernini S. Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission. Nat Reu Rheumato 1 2022:18 384-397. https://doi.org/10.1038/s41584-022-00790-8
  50. De Rycke L, Baeten D, Foell D, Kruithof E, Veys EM, Roth J, De Keyser F. Differential expression and response to anti-TNFα treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis. J Pathol 2005;206:17-27. https://doi.org/10.1002/path.1758
  51. Tanaka M, Nagai T, Tsuneyoshi Y, Sunahara N, Matsuda T, Nakamura T, Tsuyama S, Hasui K, FitzGerald O, Matsuyama T. Expansion of a unique macrophage subset in rheumatoid arthritis synovial lining layer. Clin Exp Immunol 2008;154:38-47. https://doi.org/10.1111/j.1365-2249.2008.03733.x
  52. Bostan M, Brasoveanu LI, Livescu A, Manda G, Neagu M, Iordachescu D. Effects of synovial fluid on the respiratory burst of granulocytes in rheumatoid arthritis. J Cell Moll Led 20015:188-194. https://doi.org/10.1111/j.1582-4934.2001.tb00152.x
  53. Zhang L, Yuan Y, Xu Q Jiang Z, Chu CQ. Contribution of neutrophils in the pathogenesis of rheumatoid arthritis. J Biomed Res 2020;34:86-93. https://doi.org/10.7555/JBR.33.20190075
  54. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004:303:1532-1535. https://doi.org/10.1126/science.1092385
  55. Corsiero E, Pratesi F, Prediletto E, Bombardieri M, Migliorini P. NETosis as source of autoantigens in rheumatoid arthritis. Front Immunol 2016:7:485. https://doi.org/10.3389/fimmu.2016.00485
  56. Konig MF, Andrade F. A critical reappraisal of neutrophil extracellular traps and NETosis mimics based on differential requirements for protein citrullination. Front Immunol 2016;7:461.
  57. O'Neil LJ, Kaplan MJ. Neutrophils in rheumatoid arthritis: breaking immune tolerance and fueling disease. Trends Mol Med 2019;25:215-227. PUBMEDI https://doi.org/10.1016/j.molmed.2018.12.008
  58. Chen W, Wang Q, Ke Y, Lin J. Neutrophil function in an inflammatory milieu of rheumatoid arthritis. J Immunol Res 2018;2018:8549329. https://doi.org/10.1155/2018/8549329
  59. Cascao R, Rosario HS, Souto-Carneirc MM, Fonseca JE. Neutrophils in rheumatoid arthritis: more than simple final effectors. Autoimmun Reu 2010:9:531-535. https://doi.org/10.1016/j.autrev.2009.12.013
  60. Eggleton P, Wang L, Penhallow], Crawford N, Brown KA. Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis. Ann Rheum Dis 1995:54:916-923. https://doi.org/10.1136/ard.54.11.916
  61. Fossati G, Moots RJ, Bucknall RC, Edwards SW. Differential role of neutrophil Fcy receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes. Arthritis Rheum 2002:46:1351-1361. https://doi.org/10.1002/art.10230
  62. Fresneda Alarcon M, McLaren Z, Wright HL. Neutrophils in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus: same foe different M.O. Front Immunol 2021:12:649693. https://doi.org/10.3389/fimmu.2021.649693
  63. Wright HL, Chikura B, Bucknall RC, Moots RJ, Edwards SW. Changes in expression of membrane TNF, NF-kB activation and neutrophil apoptosis during active and resolved inflammation. Ann Rheum Dis 2011;70:537-543. https://doi.org/10.1136/ard.2010.138065
  64. Wright HL, Lyon M, Chapman EA, Moots RJ, Edwards SW. Rheumatoid arthritis synovial fluid neutrophils drive inflammation through production of chemokines, reactive oxygen species, and neutrophil extracellular traps. Front Immunol 2021:11:584116. https://doi.org/10.3389/fimmu.2020.584116
  65. Wong SH, Francis N, Chahal H, Raza K, Salmon M, Scheel-Toellner D, Lord JM. Lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid. Rheumatology (Oxford) 2009;48:39-44. https://doi.org/10.1093/rheumatology/ken412
  66. Ottonello L, Cutolo M, Frumento G, Arduino N, Bertolotto M, Mancini M, Sottofattori E, Dallegri F. Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines. Rheumatology (Oxford) 2002;41:1249-1260. https://doi.org/10.1093/rheumatology/41.11.1249
  67. Wright HL, Bucknall RC, Moots RJ, Edwards SW. Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. Rheumatology (Oxford) 2012;51:451-459. https://doi.org/10.1093/rheumatology/ker338
  68. Cross A, Barnes T, Bucknall RC, Edwards SW, Moots RJ. Neutrophil apoptosis in rheumatoid arthritis is regulated by local oxygen tensions within joints. J Leukoc Biol 2006;80:521-528. https://doi.org/10.1189/jlb.0306178
  69. Bugatti S, Vitolo B, Caporali R, Montecucco C, Manzo A. B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers. Biomed Res Int 2014:2014:681678. https://doi.org/10.1155/2014/681678
  70. Wu F, Gao J, Kang J, Wang X, Niu Q, Liu J, Zhang L. B cells in rheumatoid arthritis: pathogenic mechanisms and treatment prospects. Front Immunol 2021;12:750753. https://doi.org/10.3389/fimmu.2021.750753
  71. Wardemann H, Nussenzweig MC. B-cell self-tolerance in humans. Adu Immunol 2007;95:83-110. https://doi.org/10.1016/S0065-2776(07)95003-8
  72. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med 2004;200:277-285. https://doi.org/10.1084/jem.20040165
  73. Rapetti L, Chavele KM, Evans CM, Ehrenstein MR. B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis. Ann Rheum Dis 2015;74294-302. https://doi.org/10.1136/annrheumdis-2013-204049
  74. Moura RA, Cascao R, Perpetuo I, Canhao H, Vieira-Sousa E, Mourao AF, Rodrigues AM, Polido-Pereira], Queiroz MV, Rosario HS, et al. Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival. Rheumatology (Oxford) 2011:50:278-282. https://doi.org/10.1093/rheumatology/keq338
  75. Zhang LL, Xiao H, Zhang F, Wu YJ, Shu JL, Li Y, Tai Y, Xu SQ, Xu JH, Wei W. BAFF, involved in B cell activation through the NF-κB pathway, is related to disease activity and bone destruction in rheumatoid arthritis. Acta Pharmacol Sin 2021;42:1665-1675. https://doi.org/10.1038/s41401-020-00582-4
  76. Wu H, Su S, Wu Y, Wu Y, Zhang Z, Chen Q. Nanoparticle-facilitated delivery of BAFF-R siRNA for B cell intervention and rheumatoid arthritis therapy. Int Immunopharmacol 2020;88:106933. https://doi.org/10.1016/j.intimp.2020.106933
  77. Arkatkar T, Du SW, Jacobs HM, Dam EM, Hou B, Buckner JH, Rawlings DJ, Jackson SW. B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity. J Exp Med 2017;214:3207-3217. https://doi.org/10.1084/jem.20170580
  78. Wu Q Zhou X, Huang D, Ji Y, Kang F. IL-6 enhances osteocyte-mediated osteoclastogenesis by promoting JAK2 and RANKL activity in uitro. Cell Physiol Biochem 2017;41:1360-1369. https://doi.org/10.1159/000465455
  79. Scott LJ. Tocilizumab: a review in rheumatoid arthritis. Drugs 2017;77:1865-1879. https://doi.org/10.1007/s40265-017-0829-7
  80. Romas E, Gillespie MT, Martin TJ. Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis. Bone 2002;30:340-346. https://doi.org/10.1016/S8756-3282(01)00682-2
  81. Edilova MI, Akram A, Abdul-Sater AA. Innate immunity drives pathogenesis of rheumatoid arthritis. Biomed J 2021;44 172-182. https://doi.org/10.1016/j.bj.2020.06.010
  82. Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 1999;26:717-719.
  83. Huang Q, Ma Y, Adebayo A, Pope RM. Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. Arthritis Rheum 2007;56:2192-2201. https://doi.org/10.1002/art.22707
  84. Wagner DH Jr, Stout RD, Suttles J. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur T Immunol 1994;24 3148-3154. https://doi.org/10.1002/eji.1830241235
  85. Scott BB, Weisbrot LM, Greenwood JD, Bogoch ER, Paige CJ, Keystone EC. Rheumatoid arthritis synovial fibroblast and U937 macrophage/monocyte cell line interaction in cartilage degradation. Arthritis Rheum 1997;40:490-498. https://doi.org/10.1002/art.1780400315
  86. Rivellese F, Nerviani A, Rossi FW, Marone G, Matucci-Cerinic M, de Paulis A, Pitzalis C. Mast cells in rheumatoid arthritis: friends or foes? Autoimmun Reu 2017;16:557-563. https://doi.org/10.1016/j.autrev.2017.04.001
  87. Yamin R, Berhani O, Peleg H, Aamar S, Stein N, Gamliel M, Hindi I, Scheiman-Elazary A, Gur C. High percentages and activity of synovial fluid NK cells present in patients with advanced stage active rheumatoid arthritis. Sci Rep 2019;9:1351. https://doi.org/10.1038/s41598-018-37448-z
  88. Fathollahi A, Samimi LN, Akhlaghi M, Jamshidi A, Mahmoudi M, Farhadi E. The role of NK cells in rheumatoid arthritis. Inflamm Res 2021:70:1063-1073. https://doi.org/10.1007/s00011-021-01504-8
  89. Yu MB, Langridge WHR. The function of myeloid dendritic cells in rheumatoid arthritis. Rheumatol Int 2017;37:1043-1051. https://doi.org/10.1007/s00296-017-3671-z
  90. Sarkar S, Fox DA. Dendritic cells in rheumatoid arthritis. Front Biosci 2005;10:656-665. https://doi.org/10.2741/1560
  91. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 2006;45:669-675. https://doi.org/10.1093/rheumatology/kel065
  92. Park JS, Lee D, Yang S, Jeong HY, Na HS, Cho KH, Choi J, Koo H, Cho ML, Park SH. Methotrexate-loaded nanoparticles ameliorate experimental model of autoimmune arthritis by regulating the balance of interleukin-17-producing T cells and regulatory T cells. J Transl Med 2022;20:85. https://doi.org/10.1186/s12967-022-03267-0
  93. Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, Steiner G, Smolen JS, Wagner EF, Schett G. Osteoclasts are essential for TNF-α-mediated joint destruction. J Clin Invest 2002;110:1419-1427. https://doi.org/10.1172/JCI0215582
  94. Andreas K, Libke C, Haupl T, Dehne T, Morawietz L, Ringe J, Kaps C, Sittinger M. Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in uitro study. Arthritis Res Ther 2008;10:R9 https://doi.org/10.1186/ar2358
  95. Peng X, Zhang H, Xin P, Bai G, Ge Y, Cai M, Wang R, Fan Y, Pang Z. Synovial calprotectin for the diagnosis of periprosthetic joint infection: a diagnostic meta-analysis. J Orthop Surg 2022;17:2. https://doi.org/10.1186/s13018-021-02746-2
  96. Lei s, Li Z, Zhang X, Zhou S. Efficacy and safety of progressively reducing biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in persistent remission: a study protocol for a non-inferiority randomized, controlled, single-blind trial. Trials 2022:23:600. https://doi.org/10.1186/s13063-022-06543-y
  97. Zeng X, Liu J, Liu X, Wu L, Liu Y, Liao X, Liu H, Hu J, Lu X, Chen L, et al. Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study. Arthritis Res Ther 2022:24:136. https://doi.org/10.1186/s13075-022-02821-x
  98. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegenn ligand. Nature 1999;402:304-309. https://doi.org/10.1038/46303
  99. Stach CM, Bauerle M, Englbrecht M, Kronke G, Engelke K, Manger B, Schett G. Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high-resolution computed tomography. Arthritis Rheum 2010;62:330-339. https://doi.org/10.1002/art.27252
  100. McGonagle D, Tan AL, Moller Dohn U, Ostergaard M, Benjamin M. Microanatomic studies to define predictive factors for the topography of periarticular erosion formation in inflammatory arthritis. Arthritis Rheum 2009;60:1042-1051. https://doi.org/10.1002/art.24417